Syneron Funding: $250M Raised, Series B (2026)

Syneron is based in Beijing, China. It has raised $250M in total funding. Latest round: Series B.

Syneron funding overview

Syneron is based in Beijing, China. Syneron has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in March 2026. The round record for Syneron runs through 2026; nothing later has been disclosed. Investors on record include Decheng Capital, CDH VGC, Abu Dhabi Investment Authority, True Light Capital, Qiming Venture Partners, BioTrack Capital and 11 others. 17 distinct backers are named across the disclosed rounds.

Syneron at a glance

Total raised
$250M
Latest round
Series B
Latest round date
March 2026
Headquarters
Beijing, China
Notable investors
Decheng Capital, CDH VGC, Abu Dhabi Investment Authority, True Light Capital, Qiming Venture Partners, BioTrack Capital, AstraZeneca, LAV

Frequently asked about Syneron funding

How much has Syneron raised?
Syneron has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Syneron?
Decheng Capital, CDH VGC, Abu Dhabi Investment Authority, True Light Capital, Qiming Venture Partners, BioTrack Capital are named among the investors backing Syneron.
What was the latest Syneron funding round?
The most recent disclosed round is a Series B, announced in March 2026.
Where is Syneron based?
Syneron is based in Beijing, China.
When did Syneron last raise?
The last disclosed Syneron round closed in March 2026 at Series B.

We update the Syneron record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Beijing and their backers are listed below.

Companies related to Syneron (36)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026